Close
Josh Lefkowitz
Chief Executive Officer
Josh Lefkowitz executes the company’s strategic vision to empower organizations with Business Risk Intelligence (BRI). He has worked extensively with authorities to track and analyze terrorist groups. Mr. Lefkowitz also served as a consultant to the FBI’s senior management team and worked for a top tier, global investment bank. Mr. Lefkowitz holds an MBA from Harvard University and a BA from Williams College.
Evan Kohlmann
Chief Innovation Officer
Evan Kohlmann focuses on product innovation at Flashpoint where he leverages fifteen years’ experience tracking Al-Qaida, ISIS, and other terrorist groups. He has consulted for the US Department of Defense, the US Department of Justice, the Australian Federal Police, and Scotland Yard’s Counter Terrorism Command, among others. Mr. Kohlmann holds a JD from the Univ. of Pennsylvania Law School and a BSFS in International Politics from the Walsh School of Foreign Service at Georgetown Univ.
Josh Devon
Chief Operating Officer / VP Product
Josh Devon focuses on product vision and strategy at Flashpoint while ensuring the company’s departments function synergistically during its rapid growth. He also works to ensure that customers receive best in class products, services, and support. Previously, Mr. Devon co-founded the SITE Intelligence Group where he served as Assistant Director. He holds an MA from SAIS at Johns Hopkins Univ. At the Univ. of Pennsylvania, he received a BS in Economics from the Wharton School and a BA in English from the College of Arts and Sciences.
Jennifer Leggio
Chief Marketing Officer / VP Operations
Jennifer Leggio is responsible for Flashpoint’s marketing, customer acquisition, and operations. Ms. Leggio has more than 20 years of experience driving marketing, communications and go-to-market strategies in the cybersecurity industry. She’s previously held senior leadership roles at Digital Shadows, Cisco, Sourcefire, and Fortinet. She’s been a contributor to Forbes and ZDNet, and has spoken on the importance of coordinated disclosure at DEF CON and Hack in the Box, and on threat actor “publicity” trends at RSA Conference, Gartner Security Summit, and SXSW Interactive.
Chris Camacho
Chief Strategy Officer
Chris Camacho partners with Flashpoint’s executive team to develop, communicate, and execute strategic initiatives pertaining to Business Risk Intelligence (BRI). With over 15 years of cybersecurity leadership experience, he has spearheaded initiatives across Operational Strategy, Incident Response, Threat Management, and Security Operations to ensure cyber risk postures align with business goals. Most recently as a Senior Vice President of Information Security at Bank of America, Mr. Camacho was responsible for overseeing the Threat Management Program. An entrepreneur, Mr. Camacho also serves as CEO for NinjaJobs: a career-matching community for elite cybersecurity talent. He has a BS in Decision Sciences & Management of Information Systems from George Mason University.
Lisa Iadanza
Chief People Officer
Lisa M. Iadanza leads all functional areas of People Operations at Flashpoint, including human resources, talent acquisition & management, employee engagement, and developing high performance teams. In addition to collaborating with the executive team to drive strategic growth, she plays an integral role in fostering Flashpoint’s culture and mission. Driven by her passions for mentorship, employee advocacy, and talent development, Ms. Iadanza has more than twenty years of experience in building, scaling, and leading human resources functions. Prior to Flashpoint, she held leadership roles at Conde Nast, Terra Technology, and FreeWheel. She is a member of the Society for Human Resources Management (SHRM) and holds a bachelor’s degree in management with concentrations in human resources and marketing from State University of New York at Binghamton.
Lance James
Chief Scientist / VP Engineering
Lance James is responsible for leading Flashpoint’s technology development. Prior to joining Flashpoint in 2015, he was the Head of Cyber Intelligence at Deloitte & Touche LLP. Mr. James has been an active member of the security community for over 20 years and enjoys working creatively together with technology teams to design and develop impactful solutions that disrupt online threats.
Brian Costello
SVP Global Sales and Solution Architecture
Brian Costello, a 20-year information technology and security solutions veteran, is responsible for leading the Global Sales, Solution Architecture, and Professional Services teams at Flashpoint. Throughout his career, Brian has successfully built security and cloud teams that have provided customers with innovative technology solutions, exceeded targets and consistently grown business year over year. Prior to Flashpoint, Brian led a global security and cloud vertical practice for Verizon. Brian also held senior leadership roles at Invincea, Risk Analytics and Cybertrust. Brian received his B.A. from George Mason University.
Tom Hofmann
VP Intelligence
Tom Hofmann leads the intelligence directorate that is responsible for the collection, analysis, production, and dissemination of Deep and Dark Web data. He works closely with clients to prioritize their intelligence requirements and ensures internal Flashpoint operations are aligned to those needs. Mr. Hofmann has been at the forefront of cyber intelligence operations in the commercial, government, and military sectors, and is renowned for his ability to drive effective intelligence operations to support offensive and defensive network operations.
Jake Wells
VP Customer Success
Jake Wells leads the company’s customer success team, serving as an internal advocate for our government and commercial clients to ensure Flashpoint’s intelligence solutions meet their evolving needs. He leverages a decade of experience running cyber and counterterrorism investigations, most recently with the NYPD Intelligence Bureau, to maximize the value customers generate from our products and services. Mr. Wells holds an MA from Columbia University and a BA from Emory University.
Brian Brown
VP Business Development
Brian Brown is responsible for the overall direction of strategic sales and development supporting Flashpoint’s largest clients. In his role, Mr. Brown focuses on designing and executing growth-oriented sales penetration strategies across multiple vertical markets, including both Government and Commercial, supporting Flashpoint’s Sales and Business Development Teams. An experienced entrepreneur, Mr. Brown also serves as CSO for NinjaJobs, a private community created to match elite cybersecurity talent with top tier global jobs and also advise growth-stage cybersecurity companies.

Business Risk Profile: Pharmaceuticals

Blog
March 21, 2018

Companies in the innovation-driven pharmaceutical industry are no strangers to risk. Operational risk is an inherent aspect of pharmaceutical research and development, with 4.9 percent of new drugs making it from first toxicity dose to final market approval. Pharmaceutical companies also face financial and strategic risks when bringing new drugs to market, as well as compliance risks from navigating the ever-changing regulatory landscape.

In addition to risks related to core business activity, pharmaceutical companies must also pay consideration to malicious threats, including, but not limited to:

Intellectual Property Theft and Cyber Espionage

On average, pharmaceutical companies spend $2.6 billion USD developing each new drug that is brought to market through an exhaustive, five-stage process that often takes longer than 10 years to complete. The lengthy, capital-intensive nature of developing new drugs makes intellectual property (IP) protection crucial to a pharmaceutical company’s ability to fund its R&D efforts and sustain a competitive advantage.

Given its high intrinsic value and strategic importance, pharmaceutical companies’ IP, research, and other commercially sensitive information may attract the interest of a diverse range of threat actors, ranging from rival corporations to nation states. In an industry where competitors engage in decades-long races to bring new drugs to market, corporate espionage is a legitimate threat. Meanwhile, certain nation states have even been known to conduct cyber espionage to gain an economic advantage over other countries at the forefront of technological and medical advancement. To avoid law enforcement detection, IP theft and cyber espionage schemes are often hatched within the encrypted forums of the Deep & Dark Web (DDW).

Underground Drug Trafficking

The DDW also serves as a platform for multiple underground drug marketplaces, where a wide variety of prescription drugs ranging from opioids to inhalers are illegally bought and sold. In addition to diverting revenue from pharmaceutical companies, these illicit DDW pharmacies can fuel addiction and abuse. DDW drug marketplaces also attract customers who lack health insurance and are seeking affordable treatment for legitimate reasons. However, these customers are putting their health at risk by purchasing medications without regulatory oversight or the involvement of a physician. In some cases, DDW vendors have been known to sell placebos, or worse, pills containing harmful substances.

Insider Threat

Many companies devote the majority of their security resources to defending against external threats, which is why it can be easy to overlook the ever-present risk of rogue employees abusing their privileges for personal gain at the expense of the company. Pharmaceutical companies are particularly susceptible to insider threat activity due to the astronomical value of the IP they hold and strong black-market demand for prescription drugs. Insider threat actors often operate primarily within the forums and marketplaces of the DDW when advertising stolen intellectual property, diverted drugs, network credentials, or other resources.

Threat actors who possess the level of sophistication needed to pose a legitimate threat to pharmaceutical companies will likely take considerable measures to evade detection. Without visibility into the DDW, pharmaceutical companies may be unable to proactively anticipate and mitigate threats originating from the encrypted communities of the cybercriminal underground.

Flashpoint combines extensive monitoring of DDW activity with the specialized subject-matter expertise of our analyst team to deliver Business Risk Intelligence (BRI), equipping our customers with a decision advantage over the threats and adversaries that matter to them the most.

To learn more about how pharmaceutical companies are leveraging BRI, download our Business Risk Intelligence (BRI) for Pharmaceuticals use cases.

avatar

Chris Camacho

Chief Strategy Officer

Chris Camacho partners with Flashpoint’s executive team to develop, communicate, and execute strategic initiatives. With over 15 years of cybersecurity leadership experience, he has led initiatives across Operational Strategy, Incident Response, Threat Management, and Security Operations to ensure cyber risk postures align with business goals. An entrepreneur, Mr. Camacho also serves as CEO for NinjaJobs, a career-matching community for elite cybersecurity talent. He has a BS in Decision Sciences & Management of Information Systems from George Mason University.

Flashpoint Intelligence Brief

Subscribe to our newsletter to stay up-to-date on our latest research, news, and events